GagandeepSinghTaluja

Dr Reddys Labs

看多
GagandeepSinghTaluja 已更新   
BSE:DRREDDY   DR.REDDYS LABORATORIES LTD.
2
Fundamentals-
1)A very attractive company in the space of Pharma
2)Growth rate, operating profit is facing multiyear resistance.
3)Net sales, operating profits have improved.
4)A good company to invest in for long term, FII's hold upto 36% stake(Source-BSE)


Technicals-
1)Stock is in resistance zone and if it survives this zone, a good shoot up is expected from current levels.

Keynote-->Its a good stock that can be accumulated at every dip.

Positive News1--> Franklin Templeton holds 21L shares of this company.(Source-BSE India)
Positive News2--> LIC has doubled its holding in 2016 and currently holds 26L shares of this company.(Source-BSE India, Economic times)

CMP-2857(25th Feb'2017)
Stop loss-2832
1st target-3400(6-8 months)

Disclaimer : I am a private Investor/trader who is just expressing his views. These are just my opinions and i am not giving any kind of free or paid calls. I am using this platform to share my knowledge and learn from other's knowledge. I might be/might not be invested in my opinions.
NOTE-->I give preference to the traders/investors who encourage me by commenting and liking my ideas.
評論:
Pharmeceutical sector is going through lots of USFDA downgrades but the earnings and profit of this large cap bluechip are still intact.
My opinion is a BUY for long term and this stock can be accumulated for gains
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。